Additional early-stage research and drug discovery news in brief, from: Enveric Biosciences, Gilead, Hookipa, Noxopharm, Palatin Technologies, Recludix.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advicenne, AN2, Avanzanite, Cessation, Currax, G1, Generation Bio, Ligand, Ovid, Talaris, Tourmaline, Traverse, Ultragenyx.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cellarity, Lifecore Biomedical, Microbot, SHL Medical, Vuze.
Additional early-stage research and drug discovery news in brief, from: Beyond Cancer, Biohaven, Corbus, Destiny, Myricx, Nextcure, Promontory, Storm, Venatorx.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aim, Bioaegis, Blue, Castlevax, Elevar, GRI, Immunos, Kyowa Kirin, Lumen, Lytix, Merck, Notable, Poolbeg, Revive, Sana, Seelos, Spark, Splicebio, VBL, Y-mabs.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Antiverse, Cimeio, Concentra, Fortress, Globalbio, Glycotope, Helocyte, Hudson, KBP, Legochem, Lonza, Novo Nordisk, Rain, Shaperon, Sotio, Synaffix.